3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
7
Thoracic
6
Tumor-Agnostic
1
Sarcoma
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Neoplasms
3
Neoplasm Metastasis
1
Carcinoma
1
Interventions
margetuximab
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Neoplasm Metastasis
×
Tumor-Agnostic
×
Clear all
NCT02492711
2025-03-17
SOPHIA
MacroGenics
Phase 3
Completed
624 enrolled
17 charts
1 FDA